Zhiming Liao

Title: Zhiming Liao: Innovator in Cancer Biomarkers and Antibody Therapies

Introduction

Zhiming Liao is a prominent inventor based in Ventura, CA, known for his significant contributions to the field of cancer research. With a total of 3 patents, Liao has focused on developing innovative solutions for diagnosing and treating prostate cancer.

Latest Patents

Liao's latest patents include an antibody cocktail that comprises at least three primary antibodies or fragments that specifically bind to different proteins, including AMCAR, CK 5/6, and HMWC. This invention not only enhances the diagnosis and prognosis of diseases but also assesses the efficacy of treatments. Another notable patent is related to a novel prostate cancer biomarker, villin. This invention includes compositions with anti-villin antibodies, which improve the detection of prostate cancer in subjects.

Career Highlights

Zhiming Liao is currently associated with Dako Denmark A/S, where he continues to advance his research in cancer diagnostics. His work has been instrumental in developing new methodologies that enhance the accuracy of cancer detection.

Collaborations

Liao has collaborated with notable colleagues such as Jeanette Musser and Uffe Lovborg, contributing to a dynamic research environment focused on innovative cancer solutions.

Conclusion

Zhiming Liao's work in the field of cancer biomarkers and antibody therapies showcases his dedication to improving diagnostic methods and treatment efficacy. His inventions are paving the way for advancements in cancer research and patient care.